General Biosystems, Inc

General Biosystems, Inc. is a **biotechnology** company founded in **2012** and headquartered in the **United States**. The company's slogan, "Innovative biotechnology driving high-throughput, automated DNA construct production to create blueprints for new and enhanced biological functions," reflects their dedication to advancing the field. Through high-throughput, automated systems, General Biosystems produces high-quality **DNA constructs** driven by a deep understanding of genetic information storage and programming within DNA. Their innovative approach involves programming and physically writing or printing new genetic codes, thereby creating blueprints for new or enhanced biological functions. In their most recent funding round on **17 May 2021**, the company received investment from **LYFE Capital, Yida China Holdings, JinHe Ziben, Qingdao Chuyao Huayi Venture Capital Fund Partnership**, and **Ancheng Capital**, signifying the high level of interest and confidence from notable investors in General Biosystems' innovative biotechnology endeavors.